Truvestments Capital’s Ionis Pharmaceuticals IONS Stock Holding History

Truvestments Capital’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.53K	Buy	70 +69	+6,900%	+$5.19K	﹤0.01%	886
2026 Q1	$56	Hold	1	–	–	﹤0.01%	1142
2025 Q4	$59	Hold	1	–	–	﹤0.01%	997
2025 Q3	$49	Hold	1	–	–	﹤0.01%	1008
2025 Q2	$30	Sell	1 -39	-98%	-$1.28K	﹤0.01%	948
2025 Q1	$1.21K	Buy	+40	New	+$1.31K	﹤0.01%	919
2019 Q3	–	Sell	-102	Closed	-$7K	–	704
2019 Q2	$7K	Buy	+102	New	+$7.21K	﹤0.01%	573

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Truvestments Capital's IONS Position: Q2 2026 in Review

Truvestments Capital increased its Ionis Pharmaceuticals (IONS) stake by 6,900% in Q2 2026, buying an estimated $5.19K and bringing the position to 70 shares worth $5.53K. The position accounts for ﹤0.01% of the portfolio, ranked #886.

Truvestments Capital first reported a position in IONS in Q2 2019 and has held it in 7 quarters since. The position peaked at $7K in Q2 2019. 515 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

Truvestments Capital held 70 shares of Ionis Pharmaceuticals worth $5.53K as of Q2 2026.
Truvestments Capital bought 69 Ionis Pharmaceuticals shares in Q2 2026, an estimated $5.19K.
Ionis Pharmaceuticals made up ﹤0.01% of Truvestments Capital's portfolio in Q2 2026, its #886 holding.
Truvestments Capital first reported a position in Ionis Pharmaceuticals in Q2 2019 and has held it in 7 quarters since.
Truvestments Capital's Ionis Pharmaceuticals position peaked at $7K in Q2 2019.
515 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Truvestments Capital's 13F filing for Q2 2026, filed 12 Aug 2026.